1Bailey, LB & Gregory, JF III (1999) Folate metabolism and requirements. J Nutr 129, 779–782.
2Anonymous (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338, 131–137.
4Iyengar, L & Rajalakshmi, K (1975) Effect of folic acid supplement on birth weights of infants. Am J Obstet Gynecol 122, 332–336.
5Craciunescu, CN, Brown, EC, Mar, MH, et al. (2004) Folic acid deficiency during late gestation decreases progenitor cell proliferation and increases apoptosis in fetal mouse brain. J Nutr 134, 162–166.
6Xiao, S, Hansen, DK, Horsley, ET, et al. (2005) Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues. Birth Defects Res A Clin Mol Teratol 73, 6–28.
7Zammit, S, Lewis, S, Gunnell, D, et al. (2007) Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. Schizophr Bull 33, 853–858.
8Brown, AS, Bottiglieri, T, Schaefer, CA, et al. (2007) Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 64, 31–39.
9Erbe, RE (1975) Inborn errors of folate metabolism (first of two parts). N Engl J Med 293, 753–757.
10Erbe, RW (1975) Inborn errors of folate metabolism (second of two parts). N Engl J Med 293, 807–812.
11Tamura, T, Goldenberg, RL, Chapman, VR, et al. (2005) Folate status of mothers during pregnancy and mental and psychomotor development of their children at five years of age. Pediatrics 116, 703–708.
12Jaddoe, VW, Mackenbach, JP, Moll, HA, et al. (2006) The Generation R Study: design and cohort profile. Eur J Epidemiol 21, 475–484.
13Achenbach, TM & Rescorla, LA (2000) Manual for the ASEBA Preschool Forms and Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, and Families.
14Tick, NT, van der Ende, J, Koot, HM, et al. (2007) 14-Year changes in emotional and behavioural problems of very young Dutch children. J Am Acad Child Adolesc Psychiatry 46, 1333–1340.
15Reichenberg, A, Gross, R, Weiser, M, et al. (2006) Advancing paternal age and autism. Arch Gen Psychiatry 63, 1026–1032.
16Malaspina, D, Harlap, S, Fennig, S, et al. (2001) Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry 58, 361–367.
17de Beurs, E (2004) Brief Symptom Inventory. Leiden, The Netherlands: Pits Publishers.
18Derogatis, LR & Melisaratos, N (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13, 595–605.
19Timmermans, S, Jaddoe, VW, Mackenbach, JP, et al. (2008) Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in the Netherlands: The Generation R Study. Prev Med .
20Greenblatt, JM, Huffman, LC & Reiss, AL (1994) Folic acid in neurodevelopment and child psychiatry. Prog Neuropsychopharmacol Biol Psychiatry 18, 647–660.
21Brown, AS, Susser, ES, Butler, PD, et al. (1996) Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J Nerv Ment Dis 184, 71–85.
22Fernstrom, JD (2000) Can nutrient supplements modify brain function? Am J Clin Nutr 71, Suppl. 6, 1669S–1675S.
23Scholl, TO & Johnson, WG (2000) Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 71, Suppl. 5, 1295S–1303S.
24Tamura, T & Picciano, MF (2006) Folate and human reproduction. Am J Clin Nutr 83, 993–1016.
25Kelly, YJ, Nazroo, JY, McMunn, A, et al. (2001) Birthweight and behavioural problems in children: a modifiable effect? Int J Epidemiol 30, 88–94.
26McClellan, JM, Susser, E & King, M (2006) Maternal famine, de novo mutations, and schizophrenia. JAMA 296, 582–584.
27Wolff, GL, Kodell, RL, Moore, SR, et al. (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12, 949–957.
28Brantsaeter, AL, Haugen, M, Hagve, TA, et al. (2007) Self-reported dietary supplement use is confirmed by biological markers in the Norwegian Mother and Child Cohort Study (MoBa). Ann Nutr Metab 51, 146–154.